International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 7808 - 7808
Published: April 25, 2023
Biomaterial-based
therapies
have
been
receiving
attention
for
treating
microbial
infections
mainly
to
overcome
the
increasing
number
of
drug-resistant
bacterial
strains
and
off-target
impacts
therapeutic
agents
by
conventional
strategies.
A
fibrous,
non-soluble
protein,
collagen,
is
one
most
studied
biopolymers
development
antimicrobial
biomaterials
owing
its
superior
physicochemical,
biomechanical,
biological
properties.
In
this
study,
we
reviewed
different
approaches
used
develop
collagen-based
devices,
such
as
non-pharmacological,
antibiotic,
metal
oxide,
peptide,
herbal
extract-based,
combination
approaches,
with
a
particular
focus
on
preclinical
studies
that
published
in
last
decade.
Journal of Infection and Public Health,
Journal Year:
2021,
Volume and Issue:
14(12), P. 1750 - 1766
Published: Oct. 25, 2021
Antibiotics
have
been
used
to
cure
bacterial
infections
for
more
than
70
years,
and
these
low-molecular-weight
bioactive
agents
also
a
variety
of
other
medicinal
applications.
In
the
battle
against
microbes,
antibiotics
certainly
blessing
human
civilization
by
saving
millions
lives.
Globally,
caused
multidrug-resistant
(MDR)
bacteria
are
on
rise.
being
combat
diversified
infections.
Synthetic
biology
techniques,
in
combination
with
molecular,
functional
genomic,
metagenomic
studies
bacteria,
plants,
even
marine
invertebrates
aimed
at
unlocking
world's
natural
products
faster
previous
methods
antibiotic
discovery.
There
currently
only
few
viable
remedies,
potential
preventive
limited
number
antibiotics,
thereby
necessitating
discovery
innovative
approaches
antimicrobial
therapies.
MDR
is
facilitated
biofilms,
which
makes
infection
control
complex.
this
review,
we
spotlighted
comprehensively
various
aspects
viz.
overview
era,
mode
actions
development
mechanisms
resistance
future
strategies
fight
emerging
resistant
threat.
Healthcare,
Journal Year:
2023,
Volume and Issue:
11(13), P. 1946 - 1946
Published: July 5, 2023
Antibiotics
are
among
the
most
important
discoveries
of
20th
century,
having
saved
millions
lives
from
infectious
diseases.
Microbes
have
developed
acquired
antimicrobial
resistance
(AMR)
to
many
drugs
due
high
selection
pressure
increasing
use
and
misuse
antibiotics
over
years.
The
transmission
acquisition
AMR
occur
primarily
via
a
human–human
interface
both
within
outside
healthcare
facilities.
A
huge
number
interdependent
factors
related
agriculture
govern
development
through
various
drug-resistance
mechanisms.
emergence
spread
unrestricted
antimicrobials
in
livestock
feed
has
been
major
contributing
factor.
prevalence
antimicrobial-resistant
bacteria
attained
an
incongruous
level
worldwide
threatens
global
public
health
as
silent
pandemic,
necessitating
urgent
intervention.
Therapeutic
options
infections
caused
by
limited,
resulting
significant
morbidity
mortality
with
financial
impact.
paucity
discovery
supply
new
novel
treat
life-threatening
resistant
pathogens
stands
sharp
contrast
demand.
Immediate
interventions
contain
include
surveillance
monitoring,
minimizing
over-the-counter
food
animals,
access
quality
affordable
medicines,
vaccines
diagnostics,
enforcement
legislation.
An
orchestrated
collaborative
action
between
multiple
national
international
organizations
is
required
urgently,
otherwise,
postantibiotic
era
can
be
more
real
possibility
than
apocalyptic
fantasy
for
21st
century.
This
narrative
review
highlights
on
this
basis,
mechanisms
microbial
resistance,
key
strategies
combat
resistance.
Pharmaceuticals,
Journal Year:
2023,
Volume and Issue:
16(11), P. 1615 - 1615
Published: Nov. 15, 2023
Antibiotics
have
revolutionized
medicine,
saving
countless
lives
since
their
discovery
in
the
early
20th
century.
However,
origin
of
antibiotics
is
now
overshadowed
by
alarming
rise
antibiotic
resistance.
This
global
crisis
stems
from
relentless
adaptability
microorganisms,
driven
misuse
and
overuse
antibiotics.
article
explores
subsequent
emergence
It
delves
into
mechanisms
employed
bacteria
to
develop
resistance,
highlighting
dire
consequences
drug
including
compromised
patient
care,
increased
mortality
rates,
escalating
healthcare
costs.
The
elucidates
latest
strategies
against
drug-resistant
encompassing
innovative
approaches
such
as
phage
therapy,
CRISPR-Cas9
technology,
exploration
natural
compounds.
Moreover,
it
examines
profound
impact
resistance
on
development,
rendering
pursuit
new
economically
challenging.
limitations
challenges
developing
novel
are
discussed,
along
with
hurdles
regulatory
process
that
hinder
progress
this
critical
field.
Proposals
for
modifying
facilitate
development
presented.
withdrawal
major
pharmaceutical
firms
research
examined,
potential
re-engage
interest.
also
outlines
initiatives
overcome
economic
incentivize
emphasizing
international
collaborations
partnerships.
Finally,
sheds
light
government-led
a
specific
focus
Middle
East.
discusses
proactive
measures
taken
governments
region,
Saudi
Arabia
United
Arab
Emirates,
combat
threat.
In
face
multifaceted
approach
imperative.
provides
valuable
insights
complex
landscape
challenges,
collaborative
efforts
required
ensure
future
where
remain
effective
tools
safeguarding
public
health.
Journal of Medicine Surgery and Public Health,
Journal Year:
2024,
Volume and Issue:
2, P. 100081 - 100081
Published: March 2, 2024
Antimicrobial
resistance
(AMR)
is
a
critical
global
health
issue
driven
by
antibiotic
misuse
and
overuse
in
various
sectors,
leading
to
the
emergence
of
resistant
microorganisms.
The
history
AMR
dates
back
discovery
penicillin,
with
rise
multidrug-resistant
pathogens
posing
significant
challenges
healthcare
systems
worldwide.
antibiotics
human
animal
health,
as
well
agriculture,
contributes
spread
genes,
creating
"Silent
Pandemic"
that
could
surpass
other
causes
mortality
2050.
affects
both
humans
animals,
treating
infections.
Various
mechanisms,
such
enzymatic
modification
biofilm
formation,
enable
microbes
withstand
effects
antibiotics.
lack
effective
threatens
routine
medical
procedures
lead
millions
deaths
annually
if
left
unchecked.
economic
impact
substantial,
projected
losses
trillions
dollars
financial
burdens
on
agriculture.
Artificial
intelligence
being
explored
tool
combat
improving
diagnostics
treatment
strategies,
although
data
quality
algorithmic
biases
exist.
To
address
effectively,
One
Health
approach
considers
human,
animal,
environmental
factors
crucial.
This
includes
enhancing
surveillance
systems,
promoting
stewardship
programs,
investing
research
development
for
new
antimicrobial
options.
Public
awareness,
education,
international
collaboration
are
essential
combating
preserving
efficacy
future
generations.
Life,
Journal Year:
2021,
Volume and Issue:
11(6), P. 528 - 528
Published: June 7, 2021
Antimicrobial
resistance
(AMR)
is
a
high
priority
across
countries
as
it
increases
morbidity,
mortality
and
costs.
Concerns
with
AMR
have
resulted
in
multiple
initiatives
internationally,
nationally
regionally
to
enhance
appropriate
antibiotic
utilization
sectors
reduce
AMR,
the
overuse
of
antibiotics
exacerbated
by
COVID-19
pandemic.
Effectively
tackling
crucial
for
all
countries.
Principally
narrative
review
ongoing
activities
was
undertaken
improve
antimicrobial
use
address
issues
vaccines
including
COVID-19.
Point
prevalence
surveys
been
successful
hospitals
identify
areas
quality
improvement
programs,
principally
centering
on
stewardship
programs.
These
include
reducing
prolonged
prevent
surgical
site
infections.
Multiple
education
inappropriate
prescribing
dispensing
antimicrobials
ambulatory
care
essentially
viral
infections
such
acute
respiratory
It
imperative
develop
new
indicators
given
current
concerns,
instigate
programs
clear
public
health
messaging
misinformation,
essential
pandemics.
Regular
access
effective
treatments
needed
HIV,
malaria
tuberculosis.
Key
stakeholder
groups
can
AMR.
need
be
followed
up.
Journal of Xenobiotics,
Journal Year:
2021,
Volume and Issue:
11(4), P. 197 - 214
Published: Dec. 13, 2021
With
the
advancements
of
science,
antibiotics
have
emerged
as
an
amazing
gift
to
human
and
animal
healthcare
sectors
for
treatment
bacterial
infections
other
diseases.
However,
evolution
new
strains,
along
with
excessive
use
reckless
consumption
led
unfolding
antibiotic
resistances
level.
Multidrug
resistance
is
a
potential
threat
worldwide,
escalating
at
extremely
high
rate.
Information
related
drug
resistance,
its
regulation
control
are
still
very
little.
To
interpret
onset
resistances,
investigation
on
molecular
analysis
genes,
their
distribution
mechanisms
urgently
required.
Fine-tuned
research
profile
regarding
ESKAPE
pathogen
also
necessary
multidrug
resistant
bacteria.
In
present
scenario,
interaction
SARS-CoV-2
crucial.
Tracking
in-silico
various
or
gene/s
crucial
overcoming
problem,
thus,
maintenance
relevant
databases
wise
should
be
promoted.
Creating
awareness
this
critical
situation
among
individuals
every
level
important
strengthen
fight
against
fast-growing
calamity.
The
review
aimed
provide
detailed
information
regulatory
responsible
information.
article,
we
tried
focus
correlation
between
antimicrobial
COVID-19
pandemic.
This
study
will
help
in
developing
interventions,
approaches,
strategies
handle
complexity
prevent
incidences
life-threatening
infections.
Antibiotics,
Journal Year:
2022,
Volume and Issue:
11(2), P. 182 - 182
Published: Jan. 30, 2022
The
history
of
antimicrobial
resistance
(AMR)
evolution
and
the
diversity
environmental
resistome
indicate
that
AMR
is
an
ancient
natural
phenomenon.
Acquired
a
public
health
concern
influenced
by
anthropogenic
use
antibiotics,
leading
to
selection
resistant
genes.
Data
show
spreading
globally
at
different
rates,
outpacing
all
efforts
mitigate
this
crisis.
search
for
new
antibiotic
classes
one
key
strategies
in
fight
against
AMR.
Since
1980s,
newly
marketed
antibiotics
were
either
modifications
or
improvements
known
molecules.
World
Health
Organization
(WHO)
describes
current
pipeline
as
bleak,
warns
about
scarcity
leads.
A
quantitative
qualitative
analysis
pre-clinical
clinical
indicates
few
may
reach
market
years,
predominantly
not
those
fit
innovative
requirements
tackle
challenging
spread
Diversity
innovation
are
mainstays
cope
with
rapid
discovery
development
must
address
old
novel
antibiotics.
Here,
we
review
challenges
describe
leads
mechanisms
expected
replenish
pipeline,
while
maintaining
promising
possibility
shift
chase
race
between
AMR,
preserving
effectiveness,
meeting
requirements.
Expert Opinion on Drug Safety,
Journal Year:
2022,
Volume and Issue:
21(8), P. 1089 - 1111
Published: July 23, 2022
Introduction
Antimicrobial
resistance
(AMR)
is
a
concern
as
this
increases
morbidity,
mortality,
and
costs,
with
sub-Saharan
Africa
having
the
highest
rates
globally.
Concerns
rising
AMR
have
resulted
in
international,
Pan-African,
country
activities
including
development
of
national
action
plans
(NAPs).
However,
there
variable
implementation
across
key
challenges
persisting.Areas
covered
Consequently,
an
urgent
need
to
document
current
NAP
provide
future
guidance.
This
builds
on
narrative
review
literature.Expert
Opinion
All
surveyed
African
countries
developed
their
NAPs;
however,
implementation.
Countries
Botswana
Namibia
are
yet
officially
launch
NAPs
Eswatini
only
recently
launching
its
NAP.
Cameroon
further
ahead
than
these
countries;
though
concerns
South
appears
made
greatest
strides
implementing
regular
monitoring
instigation
antimicrobial
stewardship
programs.
Key
remain
Africa.
These
include
available
personnel,
expertise,
capacity,
resources
undertake
agreed
active
surveillance,
lack
focal
points
drive
NAPs,
competing
demands
priorities
among
donors.
being
addressed,
co-ordinated
efforts
needed
reduce
AMR.
Infection and Drug Resistance,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 7515 - 7545
Published: Dec. 1, 2023
Abstract:
Antimicrobial
resistance,
referring
to
microorganisms'
capability
subsist
and
proliferate
even
when
there
are
antimicrobials
is
a
foremost
threat
public
health
globally.
The
appearance
of
antimicrobial
resistance
can
be
ascribed
anthropological,
animal,
environmental
factors.
Human-related
causes
include
overuse
misuse
in
medicine,
antibiotic-containing
cosmetics
biocides
utilization,
inadequate
sanitation
hygiene
settings.
Prophylactic
therapeutic
overuse,
using
as
feed
additives,
microbes
resistant
antibiotics
genes
animal
excreta,
residue
found
animal-origin
food
excreta
animals
related
contributive
factors
for
the
antibiotic
emergence
spread.
Environmental
including
naturally
existing
genes,
improper
disposal
unused
antimicrobials,
contamination
from
waste
settings,
farms,
pharmaceutical
industries,
use
agricultural
chemicals
facilitatet
its
Wildlife
has
plausible
role
Adopting
one-health
approach
involving
properly
humans,
improving
spaces
implementing
coordinated
governmental
regulations
crucial
combating
resistance.
Collaborative
cooperative
involvement
stakeholders
public,
veterinary
ecological
sectors
circumvent
problem
effectively.
Keywords:
one
health,
gene,
environment,
wildlife
Pharmacology & Pharmacy,
Journal Year:
2023,
Volume and Issue:
14(08), P. 271 - 328
Published: Jan. 1, 2023
Background:
Antimicrobial
resistance
(AMR)
is
a
global
health
challenge
that
has
escalated
due
to
the
inappropriate
use
of
antimicrobials
in
humans,
animals,
and
environment.
Developing
implementing
strategies
reduce
combat
AMR
critical.
Purpose:
This
study
aimed
highlight
some
can
be
implemented
address
using
One
Health
approach.
Methods:
employed
narrative
review
design
included
studies
published
from
January
2002
July
2023.
The
searched
for
literature
on
antimicrobial
stewardship
(AMS)
PubMed
Google
Scholar
2020
PRISMA
guidelines.
Results:
reveals
remains
significant
public
problem.
Its
severity
been
markedly
exacerbated
by
broader
ecological
Several
have
developed
AMR,
including
Global
Action
Plan
(GAP),
National
Plans
(NAPs),
AMS
programs,
implementation
AWaRe
classification
antimicrobials.
These
also
involve
strengthening
surveillance
consumption
resistance,
encouraging
development
new
antimicrobials,
enhancing
regulations
around
prescribing,
dispensing,
usage.
Additional
measures
include
promoting
partnerships,
combating
substandard
falsified
advocating
vaccinations,
sanitation,
hygiene
biosecurity,
as
well
exploring
alternatives
However,
these
faces
various
challenges.
challenges
low
awareness
knowledge
shortage
human
resources
capacity
building
AMS,
adequate
funding
initiatives,
limited
laboratory
capacities
surveillance,
behavioural
change
issues,
ineffective
leadership
multidisciplinary
teams.
Conclusion:
In
conclusion,
this
established
prevalent
among
Successfully
addressing
calls
collaborative,
multifaceted
Despite
this,
gaps
remain
effectively
currently
recommended
AMR.
As
result,
it
essential
reinforce
are
deployed
counter
across
human,
animal,
environmental
sectors.